|UnitedHealthcare Establishes Long-term Strategic Partnership with Quest Diagnostics|
|Beginning Jan. 1, 2019, Quest will be participating as a national provider of laboratory services for all UnitedHealthcare plan participants Partnership will include broad range of value-based programs, rewarding high quality, easily accessible laboratory services at the best value and real-time data sharing to drive more personalized care support
MINNEAPOLIS and SECAUCUS, N.J., (May 24, 2018) – UnitedHealthcare and Quest Diagnostics (NYSE: DGX) have established a long-term strategic partnershi... ||05/24/18|
|Physicians Lack the Time and Tools to Discover Hidden Risks in Patients with Chronic Conditions, Finds Study from Quest Diagnostics|
|- Nearly all physicians (95%) surveyed say they entered primary care to care for the "whole patient," yet 66 percent say they don't have time to address social and behavioral issues that could affect health.
- Fears related to medication nonadherence, falling at home, and being a burden on caregivers cited as concerns by physicians and patients -- but often not discussed during the physician visit.
- Eighty-four percent of physicians say Chronic Care Management services could be an extensi... ||05/23/18|
|Quest Diagnostics adds Helen Torley to Board of Directors|
|SECAUCUS, N.J., May 17, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Helen I. Torley was elected to serve as a director at the company's 2018 Annual Meeting of Stockholders, expanding the Board of Directors to 10 members.
Dr. Torley has served since 2014 as President, Chief Executive Officer and director of Halozyme Therapeutics, Inc., a biotechnology company focused ... ||05/17/18|
|Quest Diagnostics Declares Quarterly Cash Dividend|
|SECAUCUS, N.J., May 14, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on July 23, 2018 to shareholders of record of Quest Diagnostics common stock on July 9, 2018.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the ... ||05/14/18|